Metabolic bone disease--recent developments.
D000818:Animals; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism / Q000627:therapeutic use; D002762:Cholecalciferol / Q000378:metabolism; D004100:Dihydroxycholecalciferols / Q000378:metabolism / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005459:Fluorides / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000378:metabolism; D063065:Organophosphonates / Q000627:therapeutic use; D010001:Osteitis Deformans / Q000188:drug therapy*; D010024:Osteoporosis / Q000188:drug therapy*; D010280:Parathyroid Glands / Q000378:metabolism; D010281:Parathyroid Hormone / Q000378:metabolism; D008926:Plicamycin / Q000627:therapeutic use; D012474:Salmon; D013552:Swine
D004100:Dihydroxycholecalciferols; D004967:Estrogens; D063065:Organophosphonates; D010281:Parathyroid Hormone; D002762:Cholecalciferol; D002116:Calcitonin; D005934:Glucagon; D008926:Plicamycin; D005459:Fluorides; D002118:Calcium